Home › Billing code Q5122
Q5122
Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
Medicaid paid $2.83M on code Q5122 from 2018 through 2024, to 11 providers — the #2,985 code in the file by dollars. 74% of it was billed in Michigan.
28Total paid$2.83M
24GClaims1,420
Paid per claim line$2K
33Providers billing it11
Box 32 · Location
Where Q5122 is billed
The largest of 7 states and territories, by the billing provider's address. States cover different services and set their own rates, so the same code can mean different things in different programs.
Ranked
Top providers billing Q5122
| # | Provider | Location | Claims | Paid on Q5122 |
|---|---|---|---|---|
| 1 | Cancer & Hematology Centers of Western Mi, P.C. | Grand Rapids, MI | 886 | $1.87M |
| 2 | Desert Hematology-Oncology Medical Group INC | Rancho Mirage, CA | 195 | $332K |
| 3 | Hematology-Oncology Consultants | Hemet, CA | 95 | $247K |
| 4 | Michigan Healthcare Professionals PC | Farmington Hills, MI | 120 | $230K |
| 5 | Eastern Maine Medical Center | Bangor, ME | 14 | $46K |
| 6 | Henry Ford Health ST. John Hospital | Chicago, IL | 21 | $36K |
| 7 | University of Miami Hospital and Clinics | Miami, FL | 21 | $36K |
| 8 | Froedtert Memorial Lutheran Hospital, INC. | Milwaukee, WI | 14 | $15K |
| 9 | Solano Hematology - Oncology | Vallejo, CA | 15 | $10K |
| 10 | California Cancer Associates for Research and Excellence INC | Fresno, CA | 17 | $5K |
| 11 | Geisinger Medical Center | Danville, PA | 22 | $0.00 |